Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating)’s stock price reached a new 52-week low during trading on Monday after Stifel Nicolaus lowered their price target on the stock from $94.00 to $74.00. The stock traded as low as $31.61 and last traded at $31.63, with a volume of 24090 shares changing hands. The stock had […]